THURSDAY, Dec. 1, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. “Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI],”Continue Reading

THURSDAY, Dec. 1, 2022 (HealthDay News) — The nationwide shortage of health care professionals — a so-called “Great Resignation” of providers — is impacting patient care in ways large and small, a new HealthDay/Harris Poll shows. One in four Americans (25%) have noticed or personally experienced the impact of staffingContinue Reading

MONDAY, Nov. 28, 2022 (HealthDay News) — Eating more berries and drinking tea may help slow mental decline as you age, new research suggests. In a study of more than 900 adults, researchers found that foods like these — containing antioxidant flavonols — delivered brain benefits to older adults. FlavonolsContinue Reading

WEDNESDAY, Nov. 23, 2022 (HealthDay News) — People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag. The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed itsContinue Reading

WEDNESDAY, Nov. 23, 2022 (HealthDay News) — Millions of Americans will enjoy a hot, nutritious Thanksgiving meal thanks to their local food pantry, often staffed by volunteers. Now, new research spotlights just how important these charities are. Families who rely on pantries for food assistance come away with $600 toContinue Reading

WEDNESDAY, Nov. 23, 2022 (HealthDay News) — It’s not too late to get the latest COVID-19 booster shot. Whether it’s the bivalent vaccine from drug maker Pfizer or from Moderna, the shots offer more protection against symptomatic infection, public health officials reiterated at a White House briefing on Tuesday. However,Continue Reading